Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9980999
Method for producing dry extracts
granted -
US 9980976
Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
granted -
US 9980943
Methods of treating muscular dystrophy
granted -
US 9980936
BH4 antagonists and methods related thereto
granted -
US 9980931
Use of glycyl glutamine against depression
granted -
US 9980924
Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
granted -
US 9980961
Pyruvate kinase activators for use in therapy
granted -
US 9982356
Membrane template synthesis of microtube engines
granted -
US 9981968
Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders
granted -
US 9981092
Pressurised metered dose inhalers and method of manufacture
granted -
US 9980956
Methods and therapeutic combinations for treating tumors
granted -
US 9980904
Dry powder formulation
granted -
US 9982261
Antisense antiviral compounds and methods for treating a filovirus infection
granted -
US 9980983
Peroxide formulations and methods and applicators for using the same
granted -
US 9982000
Pyrazole compounds and method for making and using the compounds
granted -
US 9982260
Identification of structurally similar small molecules that enhance therapeutic exon skipping
granted -
US 9974742
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 9976123
Cellular seeding and co-culture of a three dimensional fibroblast construct
granted -
US 9975937
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted -
US 9976130
OPAA FL—a mutant enzyme with increased catalytic efficiency on organophosphorus compound GD
granted -
US 9975944
Synthetic peptides for the treatment of autoimmune diseases
granted -
US 9975875
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
granted -
US 9974844
Cancer vaccine compositions and methods of using the same
granted -
US 9974800
Therapy for inhibition of single-stranded RNA virus replication
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.